FOMAT Medical Research Partners with AAIM GROUP to Expand Health Research in Southern California
FOMAT Medical Research, California’s largest research site network, has joined forces with AAIM GROUP (Allergy, Asthma, and Immunology Medical Group), a well-known practice group specializing in immunology, asthma, allergy, and dermatology care. This strategic partnership marks a significant milestone, bringing together two organizations dedicated to advancing clinical research and enhancing patient outcomes across Ventura, Santa Barbara, and Los Angeles Counties. By combining FOMAT’s research infrastructure with AAIM GROUP’s clinical expertise, this collaboration opens up exciting new avenues for conducting innovative studies and delivering cutting-edge therapies to patients.
For over four decades, AAIM GROUP has built a reputation for providing prompt, compassionate care to individuals facing various health challenges. The practice, now under the leadership of Dr. Preeti Chopra and Dr. Prashant Verma, is well-positioned to leverage FOMAT’s extensive research capabilities, particularly in clinical trials. Dr. Chopra emphasized the importance of this partnership in allowing AAIM GROUP to broaden its impact: “This collaboration enables us to utilize FOMAT’s advanced research network and further our mission to transform lives through pioneering research and innovative treatments.”
With FOMAT Medical Research’s established reputation in clinical research, the partnership is set to attract sponsors and contract research organizations (CROs) looking for specialized expertise in immunology, asthma, allergy, and dermatology. The collaboration is strategically positioned to provide a more streamlined and efficient approach to clinical trials, which benefits sponsors and patients alike. The organizations aim to expedite the development of new therapies, improve patient access to cutting-edge treatments, and address the diverse health needs of the Southern California community.
Chief Growth Officer of FOMAT Medical Research, Simon A. Corman, shared his thoughts on the partnership, noting how the combined resources of both organizations will foster an innovative environment and drive meaningful advancements in patient care. He stated, “AAIM GROUP brings a wealth of knowledge and dedication to patient well-being, which aligns seamlessly with FOMAT’s commitment to transforming healthcare through diversity and research excellence. Together, we can expand research opportunities and create impactful clinical solutions.”
In the rapidly evolving field of healthcare, partnerships like this are crucial for making meaningful progress. By pooling resources, expertise, and networks, FOMAT Medical Research and AAIM GROUP are setting a foundation for breakthroughs that could have lasting impacts on the way immunology, asthma, allergy, and dermatology treatments are researched and developed. Both organizations are focused on creating a robust ecosystem for clinical research, one that invites collaboration from industry leaders, sponsors, and CROs to make significant contributions to patient care.
The partnership will also enable access to diverse patient populations across Southern California, making clinical trials more inclusive and representative. This is particularly important as healthcare providers work to ensure that treatments are developed with a broad range of patient experiences in mind. By leveraging FOMAT’s well-established research infrastructure, AAIM GROUP can offer patients access to clinical trials that they may not have had otherwise, helping to advance medical knowledge and potentially bring new treatments to market faster.
For those interested in learning more about this collaboration and how it’s set to impact the healthcare landscape in Southern California, read the full press release here to explore the strategic goals and exciting possibilities of this partnership.